Search results
Jennifer Lawrence Takes Jab at Mike Pence and 'Conversion Therapy' in GLAAD Media Awards Speech
People Magazine· 3 hours agoJennifer Lawrence blasted former Vice President Mike Pence for his alleged views on 'conversion ...
Jennifer Lawrence Takes Mike Pence to Task Over Conversion Therapy
The Daily Beast via Yahoo News· 3 hours agoBryan Bedder/Getty Images for GLAADJennifer Lawrence has chilled out a little since the peak of her...
Breakthrough therapies are saving lives, but can we afford them?
Medical Xpress· 2 hours agoLast month, Stanford became the first hospital in the nation to use a new $515,000 cell therapy to...
Jennifer Lawrence roasts Mike Pence over views on conversion therapy at GLAAD Awards
The Independent via Yahoo News· 13 hours agoJennifer Lawrence roasted former US vice president Mike Pence for his alleged beliefs on conversion ...
Anticipation mounts as Insmed's bronchiectasis therapy nears phase 3 completion
BioPharma-Reporter· 4 hours agoThe therapy has sparked significant anticipation within the medical community ahead of its phase 3...
'Horrendous birth experience left me needing therapy'
BBC via AOL· 39 minutes ago'Horrendous experience' Skye Curtis, 33, who lives in Bexhill, has a two-year-old son, born in June...
Are We Over Therapy?
The Cut· 6 hours ago“I don’t think you necessarily should be — or need to be — in therapy forever,” said Emma Mahony, a licensed therapist in Philadelphia who sometimes...
BMS Opdivo and Yervoy combo misses primary endpoint in Phase III NSCLC trial
Clinical Trials Arena via Yahoo Finance· 8 hours agoBristol Myers Squibb’s (BMS) blockbuster cancer therapies Opdivo (nivolumab) and Yervoy (ipilimumab)...
Cruz's Marriage Hits Trouble on 'Chicago Fire'
TV Insider· 2 hours agoChloe (Kristen Gutoskie) wants them to go to couples therapy, but some of their troubles stem from things he can’t change about his work. “Cruz and Chloe...
MiNK Therapeutics secures $5.8 million for cancer therapy trials By Investing.com
Investing.com· 3 hours agoThe capital is designated for advancing the clinical development of MiNK-215, an innovative cancer ...
